Valuation: Shivalik Rasayan Limited

Market Cap 5.83B 60.76M 52.98M 50.03M 45.43M 85.11M 85.47M 599M 231M 2.96B 228M 223M 9.54B P/E 2025
59.1x
P/E 2026 28.2x
Enterprise Value 6.71B 69.97M 61.02M 57.61M 52.32M 98.02M 98.43M 690M 266M 3.41B 263M 257M 10.98B EV / Sales 2025
3.4x
EV / Sales 2026 1.21x
Free-Float
42.93%
Yield 2025
0.08%
Yield 2026 0.23%
14/08 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
24/07 Shivalik Rasayan Limited announced that it expects to receive INR 152.25 million in funding from Bishnoi Exports Private Limited, Growel Remedies Limited, Kim Ginnerup ApS and other investors CI
28/05 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
27/05 Shivalik Rasayan Limited Announces Resignation of Sanjay Bansal as Non-Executive Director, Effective May 27, 2026 CI
27/05 Shivalik Rasayan Limited Recommends Final Dividend for the Financial Year 2025-26, Payable on or After October 15, 2026 CI
27/05 Shivalik Rasayan Ltd March-quarter consol net profit 45.3 million rupees RE
13/02 Shivalik Rasayan Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
14/11 Shivalik Rasayan Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
29/09/25 Shivalik Rasayan Limited Approves the Re-Designation of Mr. Ashwani Kumar Sharma as a Non-Executive, Non-Independent Director CI
13/08/25 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
31/05/25 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
30/05/25 Shivalik Rasayan Limited announces Annual dividend, payable on October 27, 2025 CI
24/04/25 Medicamen Biotech Limited announced that it has received INR 535.6816 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD and other investors CI
1 day+0.20%
1 week+2.38%
Current month+12.89%
1 month+45.16%
3 months+71.09%
6 months+53.68%
Current year+4.02%
1 week 338.1
Extreme 338.1
405.35
1 month 265.5
Extreme 265.5
413
Current year 206
Extreme 206
413
1 year 206
Extreme 206
483.95
3 years 206
Extreme 206
873.6
5 years 206
Extreme 206
1,196.8
10 years 62.04
Extreme 62.04
1,196.8
Manager TitleAgeSince
Chief Executive Officer 64 17/11/2018
Director of Finance/CFO - 01/11/2001
Compliance Officer - 01/08/2017
Director TitleAgeSince
Chairman 62 23/02/2002
Director/Board Member 67 18/07/2003
Director/Board Member - 13/11/2018
Date Insider Type Main position Quantity % Market Cap. Importance
1/7/24 Don 21,500 0.1382%
26/6/24 Sell 108,500 0.6973%
Change 5-day change 1-year change 3-year change Capi.($)
+0.20%+2.38%-22.26%-48.34% 60.76M
-1.23%-4.02%+13.65%+53.27% 53.73B
+0.11%-.--%-.--%-.--% 12.96B
+0.06%+0.75%+21.10%+191.60% 11.37B
-0.67%-4.13%+7.75%+60.11% 7.64B
-3.07%-5.30%-12.70%-7.27% 6.92B
+1.07%+0.10%+53.79%+79.07% 6.08B
+0.58%-1.98%-23.59%+40.01% 5.15B
+1.00%-2.43%-18.97%-11.04% 4.93B
+0.82%+3.08%-37.58%-35.16% 3.68B
Average -0.11%-0.58%-1.88%+32.23% 11.25B
Weighted average by Cap. -0.65%-1.98%+8.15%+52.88%

Financials

2025 2026
Net sales 3.1B 32.26M 28.13M 26.56M 24.12M 45.19M 45.38M 318M 123M 1.57B 121M 118M 5.06B 3.62B 37.69M 32.86M 31.03M 28.18M 52.79M 53.01M 372M 143M 1.84B 142M 138M 5.92B
Net income 167M 1.74M 1.52M 1.43M 1.3M 2.44M 2.45M 17.16M 6.62M 84.89M 6.54M 6.39M 273M 124M 1.29M 1.13M 1.06M 966K 1.81M 1.82M 12.75M 4.92M 63.05M 4.85M 4.75M 203M
Net Debt 768M 8M 6.98M 6.59M 5.98M 11.21M 11.25M 78.89M 30.45M 390M 30.05M 29.38M 1.26B 884M 9.22M 8.04M 7.59M 6.89M 12.91M 12.96M 90.89M 35.07M 450M 34.62M 33.85M 1.45B
Logo Shivalik Rasayan Limited
Shivalik Rasayan Limited is an India-based company. The Company’s segments are engaged in agrochemicals, active pharma ingredients (API), and pharma formulation. It is the producer of Malathion Technical and Dimethoate Technical. Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide. Dimethoate Technical is used in preparation of formulations used in the control of a range of insects and mites. It also manufactures organophosphorus-based insecticides and chemicals. It has a diverse product range and product mix in order to serve consumer requirements. The APIs are being developed and manufactured in the niche area of oncology, ARVs, cardiovascular, metabolic disorders and immunology. It offers solutions from product selection to development to commercialization for a range of oncology and non-oncology products. The Company’s oncology products include Azacitidine, Busulfan, Bortezomib, and various others.
Employees
342
Date Price Change Volume
18/09/26 INR 370.15 +0.20% 6,175
17/09/26 INR 369.40 -5.16% 8,538
16/09/26 INR 389.50 +10.04% 23,247
15/09/26 INR 353.95 -2.10% 6,169
11/09/26 INR 361.55 -1.39% 11,563
  1. Stock Market
  2. Stocks
  3. 539148 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!